Byline: Olivia Dimmer
-
First-Year Student Awarded for Human Brain-Computer Interface Research
Dillan Prasad, a first-year medical student at Feinberg, was recently recognized for outstanding research by the American Association of Neurological Surgeons.
-
Regenerating Damaged Heart Cells
Northwestern Medicine scientists have discovered a way to regenerate damaged heart muscle cells in mice, a development which may provide a new avenue for treating congenital heart defects, according to a study published in the Journal of Clinical Investigation.
-
Study Examines Surge in RSV Cases After the COVID-19 Pandemic
The surge in RSV cases following the COVID-19 pandemic may have been, in part, caused by increased testing and changes to the RSV genome, according to a Northwestern Medicine study published in Nature Communications.
-
New Genes Implicated in Multiple System Atrophy
A large international team of scientists have uncovered genetic risk factors for multiple system atrophy, according to a study published in Neuron.
-
Improving Models to Study the Human Heart
Northwestern Medicine scientists have developed a new method of measuring and optimizing the maturation process of cultured heart cells, an approach that will set the future standard for a commonly used cell model in scientific research, according to details published in Cell Reports.
-
Gene Therapies Could Transform Treatment of Rare Blood Disorders
A new gene therapy could revolutionize treatment for two rare genetic blood disorders, according to a pair of trials published in the New England Journal of Medicine.
-
Feinberg Faculty and Regulatory Affairs Welcomes New Senior Director
Joan Trimuel Williams has been named Feinberg’s senior director for Faculty and Regulatory Affairs.
-
Celebrating the MD Class of 2024
Feinberg honored the MD Class of 2024 during the medical school’s 165th commencement ceremony held in the Aon Grand Ballroom at Navy Pier on May 13.
-
How Herpes Hijacks a Ride into Cells
Northwestern Medicine scientists have discovered how herpes viruses hijack cellular transport processes to infiltrate the nervous system, according to a study published in the Proceedings of the National Academy of Sciences.
-
Weight Loss Drug Shows Benefits for Heart Failure
Semaglutide, sold under brand names Ozempic and Wegovy, can help reduce heart failure symptoms and reduce heart failure hospitalizations in patients with obesity, according to a pair of studies published in The Lancet and The New England Journal of Medicine.
